Products for Research Use Only
RegisterLogin

Lirilumab

CAT: 0931-T77423-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T77423-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
1000676-41-4
Target
Virus Protease
Related Pathways
Microbiology/Virology
Purity
0.984
Bioactivity
Lirilumab (IPH2102) is an antibody against the lethal immunoglobulin-like receptor antibody KIR2D with antitumor activity that enhances the anti-HPV + cervical cancer activity of natural killer cells through VAV1-dependent NF-κB deinhibition. It can be used to study leukemia, head and neck squamous cell carcinoma (SCCHN) .
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

1000676-41-4

PubChem
cas1000676-41-4
nameLirilumab
PubChem SID481155331
sourceBOC Sciences
Source CategoryChemical Vendors
External ID1000676-41-4
valueLive
deposit2023-05-11
modify2025-07-05
available2023-05-11
descriptionPlease note that the substance record is presented as provided to PubChem by the source (depositor).
synonyms
Lirilumab1000676-41-4Anti-KIR (1-7F9)
PubChem LinkClick here

Alternative Products

CatalogName
MBS5819212Lirilumab
GTR18333604-01Lirilumab Antibody
048085KIR (lirilumab) discontinued
KPTX233Lirilumab ELISA Kit
KBI1435KRIBIOLISA™ Lirilumab ELISA
C00226-01Lirilumab (Anti-KIR)
HW759016-01Research Grade Lirilumab
591974Lirilumab (KIRD2 subgroup)
E55B0405Lirilumab (Reference antibody)

Popular Products